Hey traders,
Keep Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) high on your radar.
After that FDA news drop, this thing has been holding gains impressively.
It’s now coiled right under that $10-per-share mark, with big potential if it clears and firms up.
With that multi-day setup forming, we could get fireworks if momentum kicks in this afternoon.
This is one of those where news, chart, and sentiment all align — watch closely.
Tim Sykes
P.S. Want to catch headline-fueled breakouts the moment they start moving? Hop into our free Telegram Channel now and don’t miss a beat.
*Past performance does not indicate future results